The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis

Clinical trial NCT00646425 · TERMINATED

Trial details

NCT number: NCT00646425
Sponsor: Cerimon Pharmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-infectious Uveitis

Start date: 2008-05-01
Primary completion: 2008-11-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.